Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
90 participants
INTERVENTIONAL
2019-08-01
2021-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Simvastatin on Cardiac Function
NCT01178710
Study on the Registration of Coronary Heart Disease Patients Undergoing PCI
NCT02888652
Safety and Efficiency Study of Loading Dose Atorvastatin in Cardiac Surgery
NCT01547455
Effects of Ulinastatin on Myocardial Protection and Blood Loss in Patients Undergoing Aortic Valve Replacement
NCT00944385
Protective Effect of Lipo-PGE1 on Myocardial Injury Following Percutaneous Coronary Intervention
NCT01245855
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
inhibiting systemic inflammatory response
Ulinastatin 5000U/kg in 20ml NS i.v. before occlusion of aorta
Ulinastatin
Ulinastatin 5000U/Kg in 20 ml NS i.v. before occlusion of aorta
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ulinastatin
Ulinastatin 5000U/Kg in 20 ml NS i.v. before occlusion of aorta
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* subject needs to have coronary artery bypass grafting surgery
* subject needs to have artificial blood vessel replacement surgery
* ASA(American Society of Anesthesiologists) score II\~III
* NYHA(New York Heart Association) II\~III
Exclusion Criteria
* history of myocardial infarction within 1 month
* history of serious pulmonary infection or endocarditis within 3 months
* history of important surgery within 6 months
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Zhongshan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hui-lin Wang, Phd
Role: PRINCIPAL_INVESTIGATOR
Fudan University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B2019-156
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.